rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1998-2-10
|
pubmed:abstractText |
End-stage congestive heart failure (CHF) is associated with a high mortality rate and is often refractory to standard medical treatment. Although parenteral inotropes have been beneficial in hospitalized patients, their use in outpatients has been limited by toxicity and tachyphylaxis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0002-8703
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9453531-Adult,
pubmed-meshheading:9453531-Aged,
pubmed-meshheading:9453531-Aged, 80 and over,
pubmed-meshheading:9453531-Cardiomyopathy, Dilated,
pubmed-meshheading:9453531-Cardiotonic Agents,
pubmed-meshheading:9453531-Drug Administration Schedule,
pubmed-meshheading:9453531-Female,
pubmed-meshheading:9453531-Heart Failure,
pubmed-meshheading:9453531-Hemodynamics,
pubmed-meshheading:9453531-Home Nursing,
pubmed-meshheading:9453531-Humans,
pubmed-meshheading:9453531-Infusion Pumps,
pubmed-meshheading:9453531-Male,
pubmed-meshheading:9453531-Middle Aged,
pubmed-meshheading:9453531-Milrinone,
pubmed-meshheading:9453531-Pilot Projects,
pubmed-meshheading:9453531-Pyridones,
pubmed-meshheading:9453531-Quality of Life,
pubmed-meshheading:9453531-Treatment Outcome,
pubmed-meshheading:9453531-Vasodilator Agents
|
pubmed:year |
1998
|
pubmed:articleTitle |
Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
|
pubmed:affiliation |
Division of Cardiology, Veterans Affairs Medical Center, and University of California, San Diego, USA.
|
pubmed:publicationType |
Journal Article
|